Advertisement

Topics

Latest Clinical Approvals NewsRSS

19:41 EDT 23rd September 2017 | BioPortfolio

Monoamine Oxidase B MAOB Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Monoamine Oxidase B MAOB InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Monoamine Oxidase B MAOB Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessm...

BetaLactamase Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1500

DelveInsight's, BetaLactamase InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across BetaLactamase Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of BetaLactamase I...

Capnia Inc SLNO Product Pipeline Analysis, 2017 Update [Report Updated: 14072017] Prices from USD $750

SummaryCapnia Inc Capnia is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company's products include serenz and cosense. Its serenz is a handheld device, which is used to obtain relief from the symptoms of allergies. Capnia's cosense is a portable device that is used to measure carbon monoxide in exhaled breath. The company pro...

Notch Signaling Pathway Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1500

DelveInsight's, Notch Signaling Pathway InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Notch Signaling Pathway Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessmen...

50S Ribosomal Subunit 50S RNA Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1500

DelveInsight's, 50S Ribosomal Subunit 50S RNA InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across 50S Ribosomal Subunit 50S RNA Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeuti...

2017 Infectious Disease Testing Market: Supplier Shares by Country, Emerging Tests and Strategic Profiles of Leading Suppliers [Report Updated: 23082017] Prices from USD $3500

This 760page report presents a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and p...

Drug Approvals Don't Always Translate Into Stock Gains: 3 Biotech Examples

Click to view a price quote on NEOS.

Marshall Edwards to Host Annual Meeting of Stockholders

    SAN DIEGO, Nov. 22, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, will host its Annual Meeting of Stockholders at 10:00 a.m. Pacific time on Thursday, December 1, 2011 at its offices, located at 11975 El Camino Real, Suite 101, San Diego, CA 92130, to ...

The Feinstein Institute for Medical Research Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryThe Feinstein Institute for Medical Research Feinstein Institute, a subsidiary of Northwell Health Inc is the research institute that provides clinical research programs. The institute conducts clinical research studies for determining the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens for various diseases. It conducts research in the areas suc...

Drug Delivery in Cancer technologies, markets and companies [Report Updated: 08092017] Prices from USD $4000

SummaryDrug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer ap...

Fatty Acid Amide Hydrolase FAAH Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Fatty Acid Amide Hydrolase FAAH InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Fatty Acid Amide Hydrolase FAAH Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therap...

Institute for Child & Family Health (ICFH) Awarded $100,000 Grant from Health Foundation of South Florida

Funding to develop health information technology infrastructure and expand the use of electronic health records MIAMI, Dec. 14, 2011 /PRNewswire-USNewswire/ -- Institute for Child and Family Health (ICFH) has received a $100,000 grant from Health Foundation of South Florida to implement electronic health records for the organization's behavioral health services. The grant funding will be u...

Invion Ltd IVX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryInvion Ltd Invion is a healthcare company that offers therapeutics. The company develops and markets products for the treatment of inflammatory diseases such as chronic inflammatory airway disease and inflammation caused by autoimmune disease. Its pipeline products include INV102 nadolol, a beta blocker for inflammatory lung conditions; INV103 alaCpn10 for reducing inflammatory markers, and...

Interleukin2 IL2 Receptor Agonist Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Interleukin2 IL2 Receptor AgonistMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Interleukin2 IL2 Receptor Agonist. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessmen...

Gemphire Therapeutics Inc GEMP Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryGemphire Therapeutics Inc Gemphire is a clinicalstage biopharmaceutical company that develops and commercializes therapies for the treatment of dyslipidemia. Its lead product, gemcabene, is an oral therapy that targets known lipid metabolic pathways, lowering levels of LDLC, hsCRP and triglycerides. The company carries out clinical trials of gemcabene in the therapeutic areas of homozygous ...

D1 Antagonist Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, D1 AntagonistMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across D1 Antagonist. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of D1 Antagonist by development stage,...

Parexel International To Present At Raymond James Investors Conference And Barclays Healthcare Conference

BOSTON, Feb. 26, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference in Orlando, FL.  James Winschel, Executive Vice President, will be making a presentation on PAREXEL and discussing business developments at 8:05 a.m.  ET on Tuesday, March 4, 2014. PAREXEL will also be presenting...

Autophagy modulators Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Autophagy modulatorsMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Autophagy modulators. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of Autophagy modulators ...

Fistula Global Clinical Trials Review, H2, 2017 [Report Updated: 23082017] Prices from USD $2500

Fistula Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, Fistula Global Clinical Trials Review, H2, 2017" provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The r...

Alpha1 Agonist Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Alpha1 AgonistMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Alpha1 Agonist. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of Alpha1 Agonist by development sta...

Mitochondrial Electron Transport Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Mitochondrial Electron Transport InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Mitochondrial Electron Transport Inhibitor. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline ther...

AntiCD279 PD1 Antibody Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1500

DelveInsight's, AntiCD279 PD1 AntibodyMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across AntiCD279 PD1 Antibody. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of AntiCD279 PD1 Ant...

Endothelin Receptor ET Antagonist Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Endothelin Receptor ET AntagonistMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Endothelin Receptor ET Antagonist. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessmen...

Haemonetics to Present at Citi 2013 Global Healthcare Conference

BRAINTREE, Mass., Feb. 13, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Citi 2013 Global Healthcare Conference in New York on February 26, 2013 at 1:30pm Eastern time.  (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access Mr. Concannon's presentation live via web...

Israeli Startup Augmedics Lands $8.3M for Augmented Reality Glasses for Spinal Surgery

Augmedics, a Yokneam, Israel-based developer of an augmented-reality (AR) surgical visualization system has raised $8.3M in Series A funding led by AO Invest, Israeli Innovation Authority, Terra Venture Partners and other undisclosed investors. The company plans to utilize the latest round of funding accelerate research and development as well as pre-clinical and clinical trials of ... Read More

Quick Search
Advertisement
 

review and buy Clinical Approvals market research data and corporate reports here